The FDA has issued a proposal to remove a common decongestant in over the counter products.

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion.

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Policies varied in the testing required, funding, processes after a positive screening result, and decision-making around concerning results. HealthDay News — Institutional leaders consider policies ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

Lumateperone, an atypical antipsychotic, is currently approved under the brand name Caplyta for the treatment of schizophrenia in adults.

Review shows lower odds of symptomatic UTI episodes in children with history of recurrent UTIs with nitrofurantoin, cranberry ...